Peregrine Capital Management’s NEVRO CORP. NVRO Stock Holding History

Peregrine Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-372,318	Closed	-$29.7M	–	328
2018 Q2	$29.7M	Buy	372,318 +10,019	+3%	+$831K	0.74%	32
2018 Q1	$31.4M	Sell	362,299 -59,597	-14%	-$4.81M	0.77%	32
2017 Q4	$29.1M	Buy	421,896 +118,436	+39%	+$9.48M	0.68%	41
2017 Q3	$27.6M	Sell	303,460 -21,876	-7%	-$1.87M	0.66%	38
2017 Q2	$24.2M	Buy	325,336 +14,574	+5%	+$1.17M	0.6%	49
2017 Q1	$29.1M	Sell	310,762 -10,717	-3%	-$971K	0.74%	33
2016 Q4	$23.4M	Buy	321,479 +59,851	+23%	+$5.12M	0.61%	44
2016 Q3	$27.3M	Buy	+261,628	New	+$23.6M	0.71%	29

Other funds holding NVRO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Peregrine Capital Management's NVRO Position: Q3 2018 in Review

Peregrine Capital Management sold out of NEVRO CORP. (NVRO) in Q3 2018, closing a stake of 372,318 shares — an estimated $29.7M sold.

Peregrine Capital Management first reported a position in NVRO in Q3 2016 and held it in 8 quarters. The position peaked at $31.4M in Q1 2018. 171 funds tracked by Wall St. Rank hold NVRO as of Q3 2018.

Peregrine Capital Management reported no remaining NEVRO CORP. position as of Q3 2018 after selling out during the quarter.
Peregrine Capital Management sold 372,318 NEVRO CORP. shares in Q3 2018, an estimated $29.7M.
Peregrine Capital Management first reported a position in NEVRO CORP. in Q3 2016 and held it in 8 quarters.
Peregrine Capital Management's NEVRO CORP. position peaked at $31.4M in Q1 2018.
171 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2018.

Based on Peregrine Capital Management's 13F filing for Q3 2018, filed 18 Oct 2018.